Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study-Reference-Cited by-同舟云学术

Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study

Published:2024-02 Issue: Volume:64 Page:152313
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Simon Teresa A.,Suissa Samy,Skovron Mary Lou,Frisell Thomas,Askling Johan,Michaud Kaleb,Pedro Sofia,Strangfeld Anja,Meissner Yvette,Boers Maarten,Hoffman Veena,Dominique Alyssa,Gomez Andres^ORCID,Hochberg Marc C.

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference23 articles.

1. Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial;Genant;Ann Rheum Dis,2008

2. Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy;Genovese;Ann Rheum Dis,2008

3. Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial;Kremer;Ann Intern Med,2006

4. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig;Kremer;N Engl J Med,2003

5. Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate;Schiff;Ann Rheum Dis,2008

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational approach to the prescription of anti-rheumatic drugs in rheumatoid arthritis: a product leaflet-based strategy in Italy;Frontiers in Immunology;2024-06-24